Stroke Mechanism in COVID-19 Infection: A Prospective Case-Control Study
COVID-19 감염의 뇌졸중 기전: 전향적 사례 통제 연구
Article
[키워드] addition
anti-dsDNA
anti-dsDNA antibody
antibody
anticoagulation
antiphospholipid antibody
aPTT
Blood
Characteristics
Coagulation
coagulation factor
Comorbidities
COVID-19
COVID-19 infection
COVID-19 negative
CRP
Cryptogenic
D-dimer
determined by
discharge
ENA
etiological
feature
ferritin
fibrinogen
Frequency
had more
hematoma
hemoglobin
homocysteine
Hospital admission
Hospital stay
In-hospital
Infection
Inflammation
INR
intracerebral hematoma
Intracerebral hemorrhage
involved
Ischemic
Ischemic Stroke
leukocyte
lymphocyte
Lymphocyte count
marker
Metrics
mortality rates
negative patients
nine
no difference
no significant difference
outcomes
pathophysiological mechanism
pathophysiological mechanisms
Patient
patients
patients with COVID-19
phenotypic
Platelet
Pneumonia
positive
positive patient
positive patients
Prospective
prospectively studied
risk
SARS-CoV-2 PCR
significantly higher
stroke
Test
Thoracic
Thrombolysis
Thrombophilia
thrombosis
Transient
Transient ischemic attack
Vascular
Viral
Viral pneumonia
was determined
[DOI] 10.1016/j.jstrokecerebrovasdis.2021.105919 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jstrokecerebrovasdis.2021.105919 PMC 바로가기 [Article Type] Article